Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II

Des Jarlais, Don C.; Perlis, Theresa E.; Stimson, Gerry V.; Poznyak, Vladimir
January 2006
BMC Public Health;2006, Vol. 6 Issue 1, p54
Academic Journal
Case Study
Background: Successful cross-national research requires methods that are both standardized across sites and adaptable to local conditions. We report on the development and implementation of the methodology underlying the survey component of the WHO Drug Injection Study Phase II - a multi-site study of risk behavior and HIV seroprevalence among Injecting Drug Users (IDUs). Methods: Standardized operational guidelines were developed by the Survey Coordinating Center in collaboration with the WHO Project Officer and participating site Investigators. Throughout the duration of the study, survey implementation at the local level was monitored by the Coordinating Center. Surveys were conducted in 12 different cities. Prior rapid assessment conducted in 10 cities provided insight into local context and guided survey implementation. Where possible, subjects were recruited both from drug abuse treatment centers and via street outreach. While emphasis was on IDUs, non-injectors were also recruited in cities with substantial non-injecting use of injectable drugs. A structured interview and HIV counseling/testing were administered. Results: Over 5,000 subjects were recruited. Subjects were recruited from both drug treatment and street outreach in 10 cities. Non-injectors were recruited in nine cities. Prior rapid assessment identified suitable recruitment areas, reduced drug users' distrust of survey staff, and revealed site-specific risk behaviors. Centralized survey coordination facilitated local questionnaire modification within a core structure, standardized data collection protocols, uniform database structure, and cross-site analyses. Major site-specific problems included: questionnaire translation difficulties; locating affordable HIV-testing facilities; recruitment from drug treatment due to limited/selective treatment infrastructure; access to specific sub-groups of drug users in the community, particularly females or higher income groups; security problems for users and interviewers, hostility from local drug dealers; and interference by local service providers. Conclusion: Rapid assessment proved invaluable in paving the way for the survey. Central coordination of data collection is crucial. While fully standardized methods may be a research ideal, local circumstances may require substantial adaptation of the methods to achieve meaningful local representation. Allowance for understanding of local context may increase rather than decrease the generalizability of the data


Related Articles

  • HIV/AIDS situation, WHO Western Pacific Region, 1998.  // Weekly Epidemiological Record;4/7/2000, Vol. 75 Issue 14, p110 

    Reports the number of HIV and AIDS cases in the World Health Organization Western Pacific Region. List of countries with declining HIV prevalence; Determination of sexually transmitted infections other than HIV; Assessment on the gonococcal susceptibility of HIV to antimicrobials.

  • AIDS: global lessons from a global epidemic. Mann, Jonathan; Wilson, Mary E. // BMJ: British Medical Journal (International Edition);12/18/93-12/25/93, Vol. 307 Issue 6919, p1574 

    Focuses on the prevalence of HIV epidemic. Role of the World Health Organization in the development of warning system for the emergence of diseases; Identification of microbial threats to health; Factors affecting the emergence of diseases.

  • Dried Blood Spot Specimens Are a Suitable Alternative Sample Type for HIV-1 Viral Load Measurement and Drug Resistance Genotyping in Patients Receiving First-Line Antiretroviral Therapy. Rottinghaus, Erin K.; Ugbena, Richard; Diallo, Karidia; Bassey, Orji; Azeez, Aderemi; DeVos, Joshua; Zhang, Guoqing; Aberle-Grasse, John; Nkengasong, John; Chunfu Yang // Clinical Infectious Diseases;4/15/2012, Vol. 54 Issue 8, p1187 

    Background. Antiretroviral therapy (ART) is being administered in developing nations at unprecedented numbers following the World Health Organization's (WHO) development of standardized first-line drug regimens. To ensure continued efficacy of these drug regimens, WHO recommends monitoring...

  • Classification of HIV infection and disease in women from Rwanda. Lifson, Alan R.; Allen, Susan // Annals of Internal Medicine;2/15/95, Vol. 122 Issue 4, p262 

    Presents a HIV staging system for sub-Saharan Africa on the basis of an evaluation of the World Health Organization (WHO) system and predictors of mortality. Classification of HIV infection and disease among the women of Kigali, Rwanda; Oral candidiasis as a strong predictor of progression and...

  • Low prices for HIV drugs are only one step forward. West, Peter A // BMJ: British Medical Journal (International Edition);2/7/2004, Vol. 328 Issue 7435, p349 

    Presents a letter to the editor in response to the article by M. Pollock and D. Price entitled "New deal from the World Health Organization," published in the September 13, 2003 edition of this journal.

  • Assisted Reproductive Technology for Men and Women Infected with Human Immunodeficiency Virus Type 1. Al-Khan, Anthony; Colon, Jose; Palta, Vidya; Bardeguez, Arlene // Clinical Infectious Diseases;1/15/2003, Vol. 36 Issue 2, p195 

    In 2001, the World Health Organization reported 4.3 million new human immunodeficiency virus (HIV) infections in adults globally, 41% of which were in women. During the year 2000, 27% of newly diagnosed HIV infections in the United States occurred in women. In developed countries, the perception...

  • WHO Lauds India's Effort to Combat HIV Abroad. Varma, K. J. M. // India -- West;7/15/2011, Vol. 36 Issue 34, pA42 

    The article reports that India was honored by World Health Organization (WHO) for its efforts in providing affordable and effective medicines to fight meningitis and HIV/AIDS in South America and Africa.

  • WHO Documents Worldwide Need for Better Drug Abuse Treatment--and Access to It. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;8/1/2012, Vol. 308 Issue 5, p442 

    The article provides information on the demand of the World Health Organization (WHO) on the treatment of drug use disorders. According to the WHO drug use disorders is a global problem but many countries do not take it in consideration. According to director of the department of mental health...

  • Commentary: Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step. Laurent, Christian // Journal of Public Health Policy;2010, Vol. 31 Issue 4, p401 

    Recent changes in guidelines (World Health Organization (WHO), USA, and likely Europe soon) all move towards earlier initiation of antiretroviral therapy in asymptomatic patients infected with human immunodeficiency virus (HIV). Sonia Menon appropriately questions the feasibility and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics